A new study published by the University of California reveals an AI tool that detects common cancer in men with 17% higher accuracy than doctors.
Cancer is one of the most devious diseases in the world that claims over 1 Crore lives globally. Early diagnosis is the best possible solution to prevent these deaths, which, due to lack of advancement, often gets delayed. The University of California has published a study that may help medical professionals overcome this challenge.
The Study reveals that an AI tool has successfully detected prostate cancer in Men with 84% accuracy, as compared to 67% accuracy by Physicians. The information came to light after UCLA published a Press Release on the study’s general outcomes. The revolutionary AI tool is called Unfold AI, made by Avenda Health in California. The software was recently cleared by the Food and Drug Administration.
Unfold AI uses an advanced algorithm to visualize the chances of cancer-based on multiple aspects of clinical data. The team that conducted the study comprised seven urologists and three radiologists, who analyzed over 60 cases of post-tumor removal patients for residual cancer signs.
The AI tool re-analyzed the same patients a few months later and found glaring differences in the results. The AI software identified a negative margin rate to calculate the absence of cancer cells surrounding the removed tissue. In a shocking revelation, the AI tool detected a 45 times greater negative margin rate, an indication of fewer cancer cells left behind.
“The AI takes the information that we currently have about a patient’s prostate cancer — like their pathology, imaging, and biopsy results — and creates a 3D cancer estimation map. The results we get from Unfold AI tell us if a patient will be better suited for focal therapy or more radical therapy, such as radical prostatectomy or radiation therapy, ensuring we optimize their cancer cure, the personalization of their cancer care, and the quality of life goals,” said Ali Kasraeian, M.D. and Urologist at Kasraeian Urology in Jacksonville, Florida.
Based on the results of the recent study, AI software can become the leading support tool for verifying cancer diagnosis at a much faster rate. However, AI trains on available sets of data to perform its required tasks, which makes diagnosing or detecting new cancer types nearly impossible. A lot more on-ground research is required to establish substantial evidence that proves the efficacy of AI in cancer detection and treatment.
